Jim Simons I Bio, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $31,383 - $21.8 Million	136,450 Added 11.85%	1,287,827 $219,000
Q2 2022 Aug 12, 2022	BUY	$0.23 - $0.46 $164,747 - $329,495	716,295 Added 164.63%	1,151,377 $304,000
Q1 2022 May 13, 2022	BUY	$0.3 - $0.61 $130,524 - $265,400	435,082 New	435,082 $186,000
Q4 2021 Feb 11, 2022	SELL	$0.55 - $1.04 $83,444 - $157,785	-151,717 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $160,820 - $230,609	151,717 New	151,717 $161,000
Q2 2020 Aug 13, 2020	SELL	$0.87 - $2.46 $34,854 - $98,554	-40,063 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.22 - $2.45 $8,813 - $98,154	40,063 New	40,063 $42,000
Q4 2019 Feb 13, 2020	SELL	$0.11 - $0.58 $4,425 - $23,335	-40,234 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.54 - $0.89 $21,726 - $35,808	40,234 New	40,234 $22,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.1M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.